| Dec 1, 2014
| 2:49 AM
There's yet another pharmaceutical campaign on the offensive, hoping to convince women with sexual problems that a drug called Flibanserin will cure them. This compound is a central nervous system formula originally studied as a remedy for depression....
| Sep 30, 2014
| 8:37 AM
The relationship between a doctor and a patient is a sacred trust and a legal bond. One of the most common treatments that doctors provide to patients is to prescribe medications. When writing a prescription, the doctor stipulates a specific medication,...
| Nov 16, 2014
| 6:08 PM
Arrowhead Research Corp. is trying to succeed where major pharmaceutical company efforts have failed in finding a cure for one of the world's most tenacious diseases.
The Pasadena biopharmaceutical company is developing so-called RNAi therapeutics. Such...
| Nov 17, 2014
Twenty years ago Jeff Baker started a promotional product company in a spare bedroom in his home in Indianapolis.
Today, that business, called Noble, has turned into a privately held multimillion-dollar niche product manufacturing company that takes...
| Nov 17, 2014
| 8:30 PM
Botox maker Allergan Inc., an Irvine company that started as a purveyor of eye drops and grew into one of the most respected pharmaceutical companies in the country, agreed to be acquired by Irish firm Actavis for $66 billion.
The deal thwarts a...
| Nov 18, 2014
| 3:18 PM
Ingredion said Tuesday its annual sales should hit $8 billion by 2019, up from $6.33 billion last year, as the ingredients-maker pushes to notch more sales from fast-growing specialty products and international markets.
The announcement comes weeks after...
| Nov 19, 2014
| 2:30 AM
Q: Recently, my doctor prescribed a 10-day course of doxycycline. I always ask for a generic since I need to pay full price. I was shocked when the pharmacist said it would be almost $65. I took this medication three years ago and I think it cost me...
| Nov 21, 2014
| 1:50 PM
After calling for a routine prescription refill, Craig Elliott got a rude shock: His bill was going up fivefold.
The 44-year-old piano tuner and guitar instructor from Elgin, who has health insurance, used to pay $20 for a three-month supply of his...
| Nov 24, 2014
| 6:41 PM
— Wall Street's big business — helping companies buy other companies — is hotter than it's been in years.
When pharmaceuticals giant Actavis said it was buying Allergan Inc. in Irvine and Halliburton said it would take over rival oil-...
| Sep 26, 2014
| 8:23 PM
For decades, Big Pharma and medical technology firms have made gifts and other payments to physicians as part of developing, testing and marketing their products, an expense long recognized as another cost of doing business.
On Tuesday, the federal...
| Dec 1, 2014
| 9:40 AM
Baxter International on Monday said it had submitted an application to the Food and Drug Administration for the approval of a key hemophilia drug.
The drug, BAX 855, is an extended-release version of its flagship hemophilia drug Advate, which is sold...